The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Abstract
Although nonclassical estrogen actions initiated at the cell surface have been described in many tissues, the identities of the membrane estrogen receptors (mERs) mediating these actions remain unclear. Here we show that GPR30, an orphan receptor unrelated to nuclear estrogen receptors, has all the binding and signaling characteristics of a mER. A high-affinity (dissociation constant 2.7 nm), limited capacity, displaceable, single binding site specific for estrogens was detected in plasma membranes of SKBR3 breast cancer cells that express GPR30 but lack nuclear estrogen receptors. Progesterone-induced increases and small interfering RNA-induced decreases in GPR30 expression in SKBR3 cells were accompanied by parallel changes in specific estradiol-17beta (E2) binding. Plasma membranes of human embryonic kidney 293 cells transfected with GPR30, but not those of untransfected cells, and human placental tissues that express GPR30 also displayed high-affinity, specific estrogen binding typical of mERs. E2 treatment of transfected cell membranes caused activation of a stimulatory G protein that is directly coupled to the receptor, indicating GPR30 is a G protein-coupled receptor (GPCR), and also increased adenylyl cyclase activity. The finding that the antiestrogens tamoxifen and ICI 182,780, and an environmental estrogen, ortho,para-dichlorodiphenyldichloroethylene (o,p'-DDE), have high binding affinities to the receptor and mimic the actions of E2 has important implications for both the development and treatment of estrogen-dependent breast cancer. GPR30 is structurally unrelated to the recently discovered family of GPCR-like membrane progestin receptors. The identification of a second distinct class of GPCR-like steroid membrane receptors suggests a widespread role for GPCRs in nonclassical steroid hormone actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
Filardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Self-citationRazandi, M., Pedram, A., Greene, G. L., & Levin, E. R. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0239 · Cited by 1,040
Multiple Actions of Steroid Hormones—A Focus on Rapid, Nongenomic Effects
Falkenstein, E., Tillmann, H.-C., Christ, M., Feuring, M., & Wehling, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01468-6 · Cited by 991
Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., & Shaul, P. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5347 · Cited by 923
Filardo, E. J., Quinn, J. A., Frackelton, A. R., & Bland, K. I. (2002) · Molecular Endocrinology · doi:10.1210/me.16.1.70 · Cited by 904
Self-citationZhu, Y., Rice, C. D., Pang, Y., Pace, M., & Thomas, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336132100 · Cited by 798
Self-citationZhu, Y., Bond, J., & Thomas, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436133100 · Cited by 709
Self-citationThornton, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091553298 · Cited by 681
Aronica, S. M., Kraus, W. L., & Katzenellenbogen, B. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8517 · Cited by 670 · cited 1×
“The nuclear P4 receptor is a potential mediator of the P4 up-regulation of GPR30 in SKBR3 cells, whereas estrogen is presumably acting via a nER-independent mechanism, possibly through GPR30 and activation of adenylyl cyclase (42), although additional experiments will be required to confirm this.”
BackgroundCarmeci, C., Thompson, D. A., Ring, H. Z., Francke, U., & Weigel, R. J. (1997) · Genomics · doi:10.1006/geno.1997.4972 · Cited by 591
Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model
Norman, A. W., Mizwicki, M. T., & Norman, D. P. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1283 · Cited by 569
Watters, J. J., Campbell, J. S., Cunningham, M. J., Krebs, E. G., & Dorsa, D. M. (1997) · Endocrinology · doi:10.1210/en.138.9.4030 · Cited by 490
Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway
Kahlert, S., Nuedling, S., van Eickels, M., Vetter, H., Meyer, R., & Grohé, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910345199 · Cited by 474
Proximal Events in Signaling by Plasma Membrane Estrogen Receptors
Razandi, M., Pedram, A., Park, S. T., & Levin, E. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205692200 · Cited by 473
Cancer and developmental exposure to endocrine disruptors.
Birnbaum, L. S., & Fenton, S. E. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.5686 · Cited by 458
Qiu, J., Bosch, M. A., Tobias, S. C., Grandy, D. K., Scanlan, T. S., Rønnekleiv, O. K., & Kelly, M. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-29-09529.2003 · Cited by 457
Maggiolini, M., Vivacqua, A., Fasanella, G., Recchia, A. G., Sisci, D., Pezzi, V., Montanaro, D., Musti, A. M., Picard, D., & Andò, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403588200 · Cited by 448
Song, R. X.-D., McPherson, R. A., Adam, L., Bao, Y., Shupnik, M., Kumar, R., & Santen, R. J. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.1.0748 · Cited by 407
Nongenomic Actions of Steroid Hormones in Reproductive Tissues*
Revelli, A., Massobrio, M., & Tesarik, J. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0322 · Cited by 396
Filardo, E. J. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00190-x · Cited by 373
Self-citationNadal, A., Ropero, A. B., Laribi, O., Maillet, M., Fuentes, E., & Soria, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11603 · Cited by 372
Discovery of Three Novel G-Protein-Coupled Receptor Genes
O'Dowd, B. F., Nguyen, T., Marchese, A., Cheng, R., Lynch, K. R., Heng, H. H. Q., Kolakowski, L. F., & George, S. R. (1998) · Genomics · doi:10.1006/geno.1998.5095 · Cited by 334
Liu, D., & Dillon, J. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200491200 · Cited by 285
Gu, Q., Korach, K. S., & Moss, R. L. (1999) · Endocrinology · doi:10.1210/endo.140.2.6500 · Cited by 233
Owman, C., Blay, P., Nilsson, C., & Lolait, S. J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1654 · Cited by 224
Takada, Y., Kato, C., Kondo, S., Korenaga, R., & Ando, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7734 · Cited by 210
Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
Vladusic, E. A., Hornby, A. E., Guerra-Vladusic, F. K., Lakins, J., & Lupu, R. (2000) · Oncology Reports · doi:10.3892/or.7.1.157 · Cited by 197
Watsona, C. (1999) · Steroids · doi:10.1016/s0039-128x(98)00107-x · Cited by 165
Estradiol Signaling via Sequestrable Surface Receptors
Benten, W. P. M., Stephan, C., Lieberherr, M., & Wunderlich, F. T. (2001) · Endocrinology · doi:10.1210/endo.142.4.8094 · Cited by 159
Loomis, A. K., & Thomas, P. (2000) · Biology of Reproduction · doi:10.1095/biolreprod62.4.995 · Cited by 157
Self-citationHawkins, M. B., & Thomas, P. (2004) · Endocrinology · doi:10.1210/en.2003-0806 · Cited by 154
Self-citationEstradiol Signaling via Sequestrable Surface Receptors
Benten, W. P. M. (2001) · Endocrinology · doi:10.1210/en.142.4.1669 · Cited by 130
Cloning of a Novel Member of the G Protein-Coupled Receptor Family Related to Peptide Receptors
Feng, Y., & Gregor, P. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6161 · Cited by 126
The plasma membrane estrogen receptor: nuclear or unclear?
Nadal, Á., Ropero, A. B., Fuentes, E., & Soria, B. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01846-0 · Cited by 71
Characterization of membrane estrogen binding proteins from rabbit uterus
Monje, P. V., & Boland, R. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00212-3 · Cited by 70
Braun, A. M., & Thomas, P. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.025825 · Cited by 65
Self-citationEstrogen receptors in human myeloma cells.
Otsuki, T., Yamada, O., Kurebayashi, J., Moriya, T., Sakaguchi, H., Kunisue, H., Yata, K., Uno, M., Yawata, Y., & Ueki, A. (2000) · PubMed · Cited by 63
Bertelsen, L. S., Barrett, K. E., & Keely, S. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311612200 · Cited by 57
17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
Kanda, N., & Watanabe, S. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12067.x · Cited by 55
Sylvia, V. L., Boyan, B. D., Dean, D. D., & Schwartz, Z. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00078-9 · Cited by 55
Progestin upregulates G‐protein‐coupled receptor 30 in breast cancer cells
Ahola, T. M., Purmonen, S., Pennanen, P. T., Zhuang, Y., Tuohimaa, P., & Ylikomi, T. J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02912.x · Cited by 51
Tsuda, H., Naito, A., Kim, C. K., Fukamachi, K., Nomoto, H., & Moore, M. A. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg052 · Cited by 32
Tailoring adjuvant treatments for the individual breast cancer patient
Gelber, R. D., Bonetti, M., Castiglione‐Gertsch, M., Coates, A. S., & Goldhirsch, A. (2003) · The Breast · doi:10.1016/s0960-9776(03)00166-8 · Cited by 18
Cited by
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses
Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs, D. R., Lee, D.-H., Shioda, T., Soto, A. M., vom Saal, F. S., Welshons, W. V., et al. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1050 · Cited by 3,209
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
Structural diversity of G protein-coupled receptors and significance for drug discovery
Lagerström, M. C., & Schiöth, H. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2518 · Cited by 1,492
G-protein-coupled receptors and cancer
Dorsam, R. T., & Gutkind, J. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2069 · Cited by 1,388
Estrogen receptor signaling mechanisms
(2019) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.01.001 · Cited by 988
Metadata
- Authors
- Thomas, P., Pang, Y., Filardo, E. J., & Dong, J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-02-01
- Volume
- 146
- Issue
- 2
- Pages
- 624-632
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2122015809
- Cited by
- 1,407
- References
- 45
- FWCI
- 33.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.